Authors/Disclosures
|
Tony W. Ho, MD
(AstraZeneca)
|
No disclosure on file |
|
Kurt A. Jaeckle, MD, FAAN
(Mayo Clinic Florida)
|
Dr. Jaeckle has stock in Entegrion, Inc. |
|
Eric Pearlman, MD
|
Dr. Pearlman has received personal compensation for serving as an employee of Eli Lilly and Co. Dr. Pearlman has received stock or an ownership interest from Eli Lilly and Co. |
|
Donald W. Lewis, MD, FAAP
(Children's Hospital Of The King's Daughters)
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
David Michelson, MD
(Loma Linda University Health Care)
|
Dr. Michelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Michelson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for OptumRx. The institution of Dr. Michelson has received research support from UCB SA. The institution of Dr. Michelson has received research support from Teva Pharmaceuticals USA. The institution of Dr. Michelson has received research support from PTC Therapeutics, Inc. The institution of Dr. Michelson has received research support from Novartis. The institution of Dr. Michelson has received research support from Biogen, Inc. Dr. Michelson has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Nancy Strickler, RN
|
No disclosure on file |
|
Robert D. Bachman, BS
(Clinical Neuroscience, BL1-12)
|
No disclosure on file |
|
|
No disclosure on file |
|
Christopher Lines
|
No disclosure on file |
|
David J. Hewitt, MD
|
No disclosure on file |